Tamnoon is a company that specializes in providing a managed cloud security remediation platform. This platform is designed to enhance cloud security by simplifying the detection and response to security issues, thereby improving the overall cloud posture for businesses. Tamnoon's solution addresses misconfigurations and vulnerabilities identified by Cloud-Native Application Protection Platform (CNAPP) tools. By combining AI technology with human expertise, the company empowers organizations to effectively remediate and prevent security problems within their cloud infrastructure. This enables both security and development teams to streamline their cloud security processes from prioritization through to remediation and prevention.
Creednz
Seed Round in 2023
Creednz is a company that specializes in financial data management and fraud prevention solutions tailored for modern corporate financial officers. Its platform employs advanced cyber-based techniques to analyze financial transaction data, aiming to reduce organizational risk associated with fraudulent activities. By correlating transaction data with information from corporate systems, banking, and real-world risk indicators, Creednz enables organizations to proactively safeguard against fraud. The company's focus is on delivering tools that enhance financial integrity and security, ensuring that corporations can effectively manage their internal financial data while minimizing exposure to potential fraud threats.
Tamnoon
Seed Round in 2023
Tamnoon is a company that specializes in providing a managed cloud security remediation platform. This platform is designed to enhance cloud security by simplifying the detection and response to security issues, thereby improving the overall cloud posture for businesses. Tamnoon's solution addresses misconfigurations and vulnerabilities identified by Cloud-Native Application Protection Platform (CNAPP) tools. By combining AI technology with human expertise, the company empowers organizations to effectively remediate and prevent security problems within their cloud infrastructure. This enables both security and development teams to streamline their cloud security processes from prioritization through to remediation and prevention.
Entitle
Seed Round in 2023
Entitle is a technology company that specializes in cloud infrastructure and Software-as-a-Service (SaaS) access management. It offers a platform that enables security teams to grant employees granular, just-in-time access to resources, providing centralized visibility, self-service options, and automated policy enforcement. This helps ensure secure and efficient administration of permissions, such as short-lived admin escalations, break-glass production access, vendor permission revocation upon contract expiration, and customer data accessibility during support ticket resolution.
CyVers
Funding Round in 2022
CyVers is an innovative security company specializing in web 3.0 technologies, focusing on enhancing cryptocurrency security to promote widespread adoption. The company develops advanced blockchain security software that detects cryptocurrency attacks in real-time through the application of geometric machine learning. CyVers' platform analyzes both on-chain and off-chain data, automatically learning user behavior patterns to proactively identify suspicious activity using machine learning anomaly detection techniques. This capability allows CyVers to serve as a critical line of defense against decentralized finance (DeFi) hacks, helping customers to safeguard their funds from theft by illicit transactions.
Wonder Robotics
Seed Round in 2022
Wonder Robotics specializes in the development of advanced autonomous systems for drones, electric vertical take-off and landing vehicles, and urban air mobility applications. The company's cutting-edge computer vision technology mimics human perception by integrating short-range 3D depth sensing with long-range 2D vision. This innovative approach enhances the drone's ability to interpret its surroundings, improving classification, shading, texture, and motion detection. One of Wonder Robotics' flagship products, WonderLand, enables VTOL drones to autonomously land on uncharted and unprepared sites without operator intervention. It conducts complex geometric analyses using proprietary algorithms and 3D sensors to ensure landing areas are free from obstacles and hazards. This technology not only enhances safety by preventing risks to nearby individuals and objects but also expands the operational capabilities of drones across various sectors, including commercial and military applications, such as package delivery, infrastructure inspection, and mapping.
Red Access
Series A in 2022
Red Access is a cybersecurity company that specializes in securing hybrid workplaces through its innovative agentless browsing security platform. Headquartered in Tel Aviv and founded by experts from the Israeli Cyber Community, the company provides a non-disruptive solution that protects devices and browsing sessions for employees both in and out of the office. Its lightweight platform enables organizations to secure all browsing activities across any browser, web app, device, and cloud service, without requiring installations or extensions. By integrating cloud and endpoint inspection, Red Access offers comprehensive protection against browser-based exploits and threats, ensuring a seamless user experience while maintaining high security standards. The company represents a significant advancement in secure browsing, setting a new benchmark for frictionless and agnostic security solutions.
Cybersixgill
Series B in 2022
Cybersixgill specializes in autonomous threat intelligence solutions aimed at enhancing cyber defense for organizations. The company provides a comprehensive Investigative Portal that offers covert access to threat intelligence sourced from the deep and dark web, delivering contextual and actionable insights for effective remediation. Its platform employs advanced algorithms to analyze threat actor behaviors and predict cybercrime, ensuring continuous monitoring and prioritized alerts. Additionally, Cybersixgill's Darkfeed™ feature enriches endpoint protection by proactively blocking malicious indicators of compromise, while the DVE Score™ offers critical insights into vulnerabilities, assessing the risk of exploitation based on threat actor intent. The company serves a diverse clientele, including global enterprises, financial services, managed security service providers, and governmental entities.
Canonic Security
Seed Round in 2022
Canonic Security is a SaaS application security platform that focuses on enhancing the security of third-party applications and integrations. It continuously profiles applications and user accounts to identify suspicious or non-compliant behavior, thereby reducing the attack surface associated with SaaS environments. The platform provides valuable insights into access intelligence and vulnerabilities, enabling security teams to detect SaaS-native threats and respond swiftly to potential risks. By streamlining the app review process and monitoring applications in real time, Canonic Security allows organizations to safely leverage the benefits of interconnected applications while managing the associated security risks effectively.
Sayata Labs Ltd., established in 2016 and headquartered in Tel Aviv, Israel, specializes in data-driven cybersecurity solutions for the insurance industry. The company's platform, Sayata, streamlines the commercial risk placement process for brokers and carriers, enabling them to issue quotes, bind, and issue policies swiftly and efficiently. By leveraging AI technology, Sayata provides actionable insights to help manage cyber risks, thereby facilitating rapid and profitable growth of cyber insurance books. As of now, over 1,000 users across 75 brokerages and carriers utilize Sayata's platform to expand their commercial risk portfolios.
Scribe Security
Seed Round in 2021
Scribe Security is a SaaS platform that focuses on securing software throughout the supply chain. It enables organizations to develop, distribute, and maintain their code while ensuring the integrity, provenance, authenticity, and reputation of code components. By providing visibility and assurance across the entire software development life cycle—from initial design to final deployment—Scribe Security helps organizations build and enforce robust software development processes. This comprehensive approach allows businesses to manage their software assets effectively and mitigate risks associated with code vulnerabilities.
Notal Vision
Series D in 2021
Notal Vision, Inc. is a diagnostic services company focused on enhancing the management of eye diseases, particularly age-related macular degeneration, by facilitating home-based monitoring for patients. Founded in 2000, the company is headquartered in Manassas, Virginia, with an additional office in Tel Aviv, Israel. Notal Vision develops a cloud-based platform that offers a variety of tools, including ForeseeHome, an at-home monitoring device that detects and characterizes visual disturbances, and the Notal OCT Analyzer, which employs image analysis algorithms for the automated detection of pathological fluid in retinal diseases. The company also utilizes AI algorithms to provide diagnostic decision support, enabling patients to engage in testing and treatment in collaboration with their eye care providers. By extending eye disease management beyond the clinical setting, Notal Vision aims to improve visual outcomes for patients.
ZenGo is a developer of a non-custodial cryptocurrency wallet that aims to enhance accessibility within the global crypto economy. The company utilizes advanced multiparty computation (MPC) cryptography to ensure security by default, boasting over one million customers and a record of zero hacks. ZenGo's digital wallets enable users to buy and sell cryptocurrencies while efficiently generating and managing private keys. This innovative approach addresses issues related to security breaches and human error, allowing cryptocurrency traders and investors to manage their digital assets and investment portfolios conveniently and securely.
BrainsGate
Series F in 2020
BrainsGate, Ltd. is a medical device company based in Caesarea, Israel, specializing in therapies for central nervous system diseases, particularly acute ischemic stroke. Founded in 2000, the company has developed a technology platform that utilizes electrical stimulation of the spheno-palatine ganglion (SPG) to enhance cerebral blood flow. Its innovative treatment approach involves a miniature electrode implanted in the roof of the mouth through a minimally invasive procedure performed under local anesthesia. BrainsGate's key product is an ischemic stroke system that delivers targeted stimulation to the SPG, with the aim of improving outcomes for stroke patients. The company has conducted significant clinical trials, including a pivotal study with 300 participants that demonstrated the safety and efficacy of its treatment. Currently, BrainsGate is advancing the ImpACT-24b trial, a multinational randomized study assessing the treatment's effectiveness within a critical 24-hour window following stroke onset.
Cybersixgill
Series B in 2020
Cybersixgill specializes in autonomous threat intelligence solutions aimed at enhancing cyber defense for organizations. The company provides a comprehensive Investigative Portal that offers covert access to threat intelligence sourced from the deep and dark web, delivering contextual and actionable insights for effective remediation. Its platform employs advanced algorithms to analyze threat actor behaviors and predict cybercrime, ensuring continuous monitoring and prioritized alerts. Additionally, Cybersixgill's Darkfeed™ feature enriches endpoint protection by proactively blocking malicious indicators of compromise, while the DVE Score™ offers critical insights into vulnerabilities, assessing the risk of exploitation based on threat actor intent. The company serves a diverse clientele, including global enterprises, financial services, managed security service providers, and governmental entities.
Zengold
Angel Round in 2019
Shenzhen ZenGold Culture Development Co., LTD. operates in the field of blockchain technology, specifically focusing on the trading and management of gold assets. The company has developed a decentralized application that utilizes blockchain to facilitate gold spot trading, providing users with real-time price quotes sourced from the Shanghai Gold Exchange. ZenGold also offers custody services for physical gold assets and enables delivery options. The physical assets are underwritten by Sunshine Insurance Company, ensuring security and reliability for users in China and beyond.
Sayata Labs Ltd., established in 2016 and headquartered in Tel Aviv, Israel, specializes in data-driven cybersecurity solutions for the insurance industry. The company's platform, Sayata, streamlines the commercial risk placement process for brokers and carriers, enabling them to issue quotes, bind, and issue policies swiftly and efficiently. By leveraging AI technology, Sayata provides actionable insights to help manage cyber risks, thereby facilitating rapid and profitable growth of cyber insurance books. As of now, over 1,000 users across 75 brokerages and carriers utilize Sayata's platform to expand their commercial risk portfolios.
Alcide.IO Ltd. specializes in security and management tools designed for hybrid, multi-cloud, and multi-compute data centers, with a strong focus on Kubernetes environments. Founded in 2016 and based in Tel Aviv-Yafo, Israel, the company offers an end-to-end Kubernetes security platform that includes solutions such as Alcide Kubernetes Advisor, Alcide kAudit, and Alcide Runtime. These tools help organizations secure their Kubernetes deployments by addressing configuration risks, network security events, and providing a unified policy framework. Alcide's offerings are compatible with major cloud platforms like AWS, Azure, and Google Cloud, enabling businesses to scale their Kubernetes environments while maintaining robust security measures. Its platform aims to protect against various cyber threats, including internal malicious activities and data exfiltration, ensuring the secure operation of business applications in cloud deployments.
ZenGo is a developer of a non-custodial cryptocurrency wallet that aims to enhance accessibility within the global crypto economy. The company utilizes advanced multiparty computation (MPC) cryptography to ensure security by default, boasting over one million customers and a record of zero hacks. ZenGo's digital wallets enable users to buy and sell cryptocurrencies while efficiently generating and managing private keys. This innovative approach addresses issues related to security breaches and human error, allowing cryptocurrency traders and investors to manage their digital assets and investment portfolios conveniently and securely.
Nitinotes
Series A in 2018
Nitinotes is a medical technology company specializing in minimally invasive gastrointestinal solutions. The company has introduced the EndoZip™, an automated gastroscopic suturing system designed for gastroenterologists and surgeons. This innovative system allows for safer and simpler gastrointestinal suturing, facilitating a non-surgical approach to bariatric treatment. By mimicking laparoscopic sleeve gastrectomy, the EndoZip™ enables effective weight-loss procedures for patients classified as obese class I and II, particularly those for whom traditional bariatric surgery is not suitable. Nitinotes aims to provide a widely accessible solution for endoscopic weight-loss treatments, ultimately helping patients achieve better health outcomes through advanced medical technology.
Alcide.IO Ltd. specializes in security and management tools designed for hybrid, multi-cloud, and multi-compute data centers, with a strong focus on Kubernetes environments. Founded in 2016 and based in Tel Aviv-Yafo, Israel, the company offers an end-to-end Kubernetes security platform that includes solutions such as Alcide Kubernetes Advisor, Alcide kAudit, and Alcide Runtime. These tools help organizations secure their Kubernetes deployments by addressing configuration risks, network security events, and providing a unified policy framework. Alcide's offerings are compatible with major cloud platforms like AWS, Azure, and Google Cloud, enabling businesses to scale their Kubernetes environments while maintaining robust security measures. Its platform aims to protect against various cyber threats, including internal malicious activities and data exfiltration, ensuring the secure operation of business applications in cloud deployments.
Audioburst
Series A in 2017
Audioburst Ltd. is an audio content search and discovery platform that utilizes artificial intelligence to provide real-time access to a vast library of audio content, including radio, television, and podcasts. Founded in 2015 and headquartered in Palo Alto, California, with additional offices in Tel Aviv, Israel, and Tokyo, Japan, Audioburst tailors audio content to users based on their preferences and listening habits. The company offers a suite of tools through the Audioburst Creators platform, enabling podcasters and radio show producers to transcribe, edit, amplify, and monetize their audio content. Additionally, Audioburst Studio allows for the seamless integration of curated audio playlists into existing applications or websites, while Audioburst Auto caters specifically to drivers by providing customized playlists and hands-free voice search functionality. Through these services, Audioburst aims to enhance the listening experience across various devices.
Nitinotes
Seed Round in 2016
Nitinotes is a medical technology company specializing in minimally invasive gastrointestinal solutions. The company has introduced the EndoZip™, an automated gastroscopic suturing system designed for gastroenterologists and surgeons. This innovative system allows for safer and simpler gastrointestinal suturing, facilitating a non-surgical approach to bariatric treatment. By mimicking laparoscopic sleeve gastrectomy, the EndoZip™ enables effective weight-loss procedures for patients classified as obese class I and II, particularly those for whom traditional bariatric surgery is not suitable. Nitinotes aims to provide a widely accessible solution for endoscopic weight-loss treatments, ultimately helping patients achieve better health outcomes through advanced medical technology.
Alcide.IO Ltd. specializes in security and management tools designed for hybrid, multi-cloud, and multi-compute data centers, with a strong focus on Kubernetes environments. Founded in 2016 and based in Tel Aviv-Yafo, Israel, the company offers an end-to-end Kubernetes security platform that includes solutions such as Alcide Kubernetes Advisor, Alcide kAudit, and Alcide Runtime. These tools help organizations secure their Kubernetes deployments by addressing configuration risks, network security events, and providing a unified policy framework. Alcide's offerings are compatible with major cloud platforms like AWS, Azure, and Google Cloud, enabling businesses to scale their Kubernetes environments while maintaining robust security measures. Its platform aims to protect against various cyber threats, including internal malicious activities and data exfiltration, ensuring the secure operation of business applications in cloud deployments.
Cybersixgill
Series A in 2016
Cybersixgill specializes in autonomous threat intelligence solutions aimed at enhancing cyber defense for organizations. The company provides a comprehensive Investigative Portal that offers covert access to threat intelligence sourced from the deep and dark web, delivering contextual and actionable insights for effective remediation. Its platform employs advanced algorithms to analyze threat actor behaviors and predict cybercrime, ensuring continuous monitoring and prioritized alerts. Additionally, Cybersixgill's Darkfeed™ feature enriches endpoint protection by proactively blocking malicious indicators of compromise, while the DVE Score™ offers critical insights into vulnerabilities, assessing the risk of exploitation based on threat actor intent. The company serves a diverse clientele, including global enterprises, financial services, managed security service providers, and governmental entities.
IRONSCALES
Seed Round in 2016
Ironscales Ltd. is a cybersecurity company that specializes in phishing mitigation solutions aimed at protecting organizations from cyber attacks. Founded in 2013 and headquartered in Kfar Saba, Israel, the company offers a comprehensive platform that combines machine learning and human intelligence to address the challenges of email phishing. Its services include phishing simulation training, real-life spear-phishing campaigns, automated incident response, and analysis reports. The platform is designed to engage employees through gamified training experiences, fostering a proactive approach to cybersecurity by assessing and reducing susceptibility to phishing attempts. Ironscales enables corporate information security officers to create a human-based intrusion prevention system, enhancing the overall security posture of enterprises.
Coramaze Technologies
Series A in 2015
Coramaze Technologies is a medical device company that specializes in developing innovative solutions for heart valve repair. Founded in 2013 and based in Munich, Germany, the company focuses on creating minimally invasive devices aimed at treating structural heart valve diseases. Its flagship product, the mitramaze valve repair system, is designed for implantation directly into the beating heart and targets inoperable and asymptomatic patients. Additionally, Coramaze is developing the Tripair implant, an adaptive tricuspid valve repair device that allows for a-traumatic anchoring in the right atrium, facilitating quick and straightforward procedures in catheterization laboratories. Through these advancements, Coramaze Technologies aims to improve treatment options for patients suffering from functional mitral regurgitation and other related conditions.
POCARED Diagnostics
Venture Round in 2015
POCARED Diagnostics Ltd. is a medical device company based in Rehovot, Israel, that specializes in innovative in-vitro diagnostic solutions. Founded in 2004, the company has developed a next-generation microbiology platform known as the P-1000, which enables real-time, reagentless analysis of human fluids and specimens. This fully automated system allows for the rapid detection, quantification, and identification of pathogenic bacteria and yeast, significantly reducing the time required for result reporting from several days to just minutes. By streamlining the diagnostic process, POCARED Diagnostics enhances the ability of physicians to quickly diagnose and treat infectious diseases, ultimately improving patient outcomes. The company operates as a subsidiary of Naftali Investments Ltd.
CartiHeal
Series D in 2015
CartiHeal Ltd. is a medical device company based in Kfar Sava, Israel, specializing in the development of innovative solutions for cartilage and bone disorders. Founded in 2009, the company has pioneered a cell-free implant technology known as Agili-C, designed to address focal articular cartilage and osteochondral defects. This off-the-shelf implant promotes the regeneration of true hyaline cartilage and its underlying subchondral bone through a minimally invasive procedure, without the need for cells or growth factors. CartiHeal's Agili-C implant represents a significant advancement in the treatment of cartilage injuries, which can lead to severe pain, disability, and early onset of osteoarthritis if left untreated. By offering a well-tolerated and effective solution, CartiHeal aims to meet a critical need in the field of cartilage repair and regeneration.
BrainsGate
Venture Round in 2015
BrainsGate, Ltd. is a medical device company based in Caesarea, Israel, specializing in therapies for central nervous system diseases, particularly acute ischemic stroke. Founded in 2000, the company has developed a technology platform that utilizes electrical stimulation of the spheno-palatine ganglion (SPG) to enhance cerebral blood flow. Its innovative treatment approach involves a miniature electrode implanted in the roof of the mouth through a minimally invasive procedure performed under local anesthesia. BrainsGate's key product is an ischemic stroke system that delivers targeted stimulation to the SPG, with the aim of improving outcomes for stroke patients. The company has conducted significant clinical trials, including a pivotal study with 300 participants that demonstrated the safety and efficacy of its treatment. Currently, BrainsGate is advancing the ImpACT-24b trial, a multinational randomized study assessing the treatment's effectiveness within a critical 24-hour window following stroke onset.
POCARED Diagnostics
Series G in 2014
POCARED Diagnostics Ltd. is a medical device company based in Rehovot, Israel, that specializes in innovative in-vitro diagnostic solutions. Founded in 2004, the company has developed a next-generation microbiology platform known as the P-1000, which enables real-time, reagentless analysis of human fluids and specimens. This fully automated system allows for the rapid detection, quantification, and identification of pathogenic bacteria and yeast, significantly reducing the time required for result reporting from several days to just minutes. By streamlining the diagnostic process, POCARED Diagnostics enhances the ability of physicians to quickly diagnose and treat infectious diseases, ultimately improving patient outcomes. The company operates as a subsidiary of Naftali Investments Ltd.
CartiHeal
Venture Round in 2013
CartiHeal Ltd. is a medical device company based in Kfar Sava, Israel, specializing in the development of innovative solutions for cartilage and bone disorders. Founded in 2009, the company has pioneered a cell-free implant technology known as Agili-C, designed to address focal articular cartilage and osteochondral defects. This off-the-shelf implant promotes the regeneration of true hyaline cartilage and its underlying subchondral bone through a minimally invasive procedure, without the need for cells or growth factors. CartiHeal's Agili-C implant represents a significant advancement in the treatment of cartilage injuries, which can lead to severe pain, disability, and early onset of osteoarthritis if left untreated. By offering a well-tolerated and effective solution, CartiHeal aims to meet a critical need in the field of cartilage repair and regeneration.
POCARED Diagnostics
Series F in 2013
POCARED Diagnostics Ltd. is a medical device company based in Rehovot, Israel, that specializes in innovative in-vitro diagnostic solutions. Founded in 2004, the company has developed a next-generation microbiology platform known as the P-1000, which enables real-time, reagentless analysis of human fluids and specimens. This fully automated system allows for the rapid detection, quantification, and identification of pathogenic bacteria and yeast, significantly reducing the time required for result reporting from several days to just minutes. By streamlining the diagnostic process, POCARED Diagnostics enhances the ability of physicians to quickly diagnose and treat infectious diseases, ultimately improving patient outcomes. The company operates as a subsidiary of Naftali Investments Ltd.
CartiHeal
Venture Round in 2012
CartiHeal Ltd. is a medical device company based in Kfar Sava, Israel, specializing in the development of innovative solutions for cartilage and bone disorders. Founded in 2009, the company has pioneered a cell-free implant technology known as Agili-C, designed to address focal articular cartilage and osteochondral defects. This off-the-shelf implant promotes the regeneration of true hyaline cartilage and its underlying subchondral bone through a minimally invasive procedure, without the need for cells or growth factors. CartiHeal's Agili-C implant represents a significant advancement in the treatment of cartilage injuries, which can lead to severe pain, disability, and early onset of osteoarthritis if left untreated. By offering a well-tolerated and effective solution, CartiHeal aims to meet a critical need in the field of cartilage repair and regeneration.
CartiHeal
Series D in 2012
CartiHeal Ltd. is a medical device company based in Kfar Sava, Israel, specializing in the development of innovative solutions for cartilage and bone disorders. Founded in 2009, the company has pioneered a cell-free implant technology known as Agili-C, designed to address focal articular cartilage and osteochondral defects. This off-the-shelf implant promotes the regeneration of true hyaline cartilage and its underlying subchondral bone through a minimally invasive procedure, without the need for cells or growth factors. CartiHeal's Agili-C implant represents a significant advancement in the treatment of cartilage injuries, which can lead to severe pain, disability, and early onset of osteoarthritis if left untreated. By offering a well-tolerated and effective solution, CartiHeal aims to meet a critical need in the field of cartilage repair and regeneration.
BrainsGate
Series C in 2011
BrainsGate, Ltd. is a medical device company based in Caesarea, Israel, specializing in therapies for central nervous system diseases, particularly acute ischemic stroke. Founded in 2000, the company has developed a technology platform that utilizes electrical stimulation of the spheno-palatine ganglion (SPG) to enhance cerebral blood flow. Its innovative treatment approach involves a miniature electrode implanted in the roof of the mouth through a minimally invasive procedure performed under local anesthesia. BrainsGate's key product is an ischemic stroke system that delivers targeted stimulation to the SPG, with the aim of improving outcomes for stroke patients. The company has conducted significant clinical trials, including a pivotal study with 300 participants that demonstrated the safety and efficacy of its treatment. Currently, BrainsGate is advancing the ImpACT-24b trial, a multinational randomized study assessing the treatment's effectiveness within a critical 24-hour window following stroke onset.
CartiHeal
Series C in 2011
CartiHeal Ltd. is a medical device company based in Kfar Sava, Israel, specializing in the development of innovative solutions for cartilage and bone disorders. Founded in 2009, the company has pioneered a cell-free implant technology known as Agili-C, designed to address focal articular cartilage and osteochondral defects. This off-the-shelf implant promotes the regeneration of true hyaline cartilage and its underlying subchondral bone through a minimally invasive procedure, without the need for cells or growth factors. CartiHeal's Agili-C implant represents a significant advancement in the treatment of cartilage injuries, which can lead to severe pain, disability, and early onset of osteoarthritis if left untreated. By offering a well-tolerated and effective solution, CartiHeal aims to meet a critical need in the field of cartilage repair and regeneration.
POCARED Diagnostics
Series F in 2011
POCARED Diagnostics Ltd. is a medical device company based in Rehovot, Israel, that specializes in innovative in-vitro diagnostic solutions. Founded in 2004, the company has developed a next-generation microbiology platform known as the P-1000, which enables real-time, reagentless analysis of human fluids and specimens. This fully automated system allows for the rapid detection, quantification, and identification of pathogenic bacteria and yeast, significantly reducing the time required for result reporting from several days to just minutes. By streamlining the diagnostic process, POCARED Diagnostics enhances the ability of physicians to quickly diagnose and treat infectious diseases, ultimately improving patient outcomes. The company operates as a subsidiary of Naftali Investments Ltd.
BPT is developing and commercializing advanced membranes-based separation solutions addressing the unique needs of the water and wastewater treatment for key industrial processes. BPT patented chemically-stable membrane technology enable customers in the landfill, mining, chemical, biopharma and food industries to comply with the environmental regulations, reuse water and reduce production costs. BPT membranes are field proven to enable lowest cost reclamation of some of the most aggressive and vexing industrial waste water streams.
CartiHeal
Series A in 2009
CartiHeal Ltd. is a medical device company based in Kfar Sava, Israel, specializing in the development of innovative solutions for cartilage and bone disorders. Founded in 2009, the company has pioneered a cell-free implant technology known as Agili-C, designed to address focal articular cartilage and osteochondral defects. This off-the-shelf implant promotes the regeneration of true hyaline cartilage and its underlying subchondral bone through a minimally invasive procedure, without the need for cells or growth factors. CartiHeal's Agili-C implant represents a significant advancement in the treatment of cartilage injuries, which can lead to severe pain, disability, and early onset of osteoarthritis if left untreated. By offering a well-tolerated and effective solution, CartiHeal aims to meet a critical need in the field of cartilage repair and regeneration.
PLYmedia, Inc. is an ad-tech company based in Palo Alto, California, founded in 2006. Specializing in performance-based advertising, PLYmedia develops innovative solutions for ad networks, including PLYexchange, a performance advertising ecosystem that leverages a highly accurate prediction engine and real-time bidding to enhance advertising effectiveness. The company also offers PLYvideo, a video advertising solution tailored for ad networks and agencies, and Adk2, a white label performance-based ad exchange. By focusing on maximizing the performance of internet advertising and establishing a global ecosystem that prioritizes quality supply and demand, PLYmedia aims to address the specific needs of its partners in the advertising landscape.
BrainsGate
Series C in 2008
BrainsGate, Ltd. is a medical device company based in Caesarea, Israel, specializing in therapies for central nervous system diseases, particularly acute ischemic stroke. Founded in 2000, the company has developed a technology platform that utilizes electrical stimulation of the spheno-palatine ganglion (SPG) to enhance cerebral blood flow. Its innovative treatment approach involves a miniature electrode implanted in the roof of the mouth through a minimally invasive procedure performed under local anesthesia. BrainsGate's key product is an ischemic stroke system that delivers targeted stimulation to the SPG, with the aim of improving outcomes for stroke patients. The company has conducted significant clinical trials, including a pivotal study with 300 participants that demonstrated the safety and efficacy of its treatment. Currently, BrainsGate is advancing the ImpACT-24b trial, a multinational randomized study assessing the treatment's effectiveness within a critical 24-hour window following stroke onset.
ChipX, Inc. is a Mixed-Signal ASIC company with the broadest offering of value-added ASIC solutions, including Standard Cell, Structured ASIC and Hybrid ASIC technology. ChipX has unique expertise in PCI Express, USB 2.0, DDR/DDR2 and data conversion mixed-signal cores; all are silicon proven and certified and they can be integrated in customers’ ASICs with a record first-time to market success. ChipX products are widely used in industrial applications, medical equipment and military/aerospace systems. Headquartered in Santa Clara, CA, ChipX is a privately held corporation, with a Research and Development subsidiary in Israel.
Aqwise
Venture Round in 2008
Aqwise - Wise Water Technologies Ltd. is a leading provider of innovative wastewater treatment solutions for both industrial and municipal markets. The company specializes in enhancing biological oxygen demand (BOD) and nutrient removal capacities in wastewater treatment plants, optimizing the use of existing reactors, and improving the efficiency of new installations. Aqwise offers a comprehensive range of services, including process design, project supervision, and full turn-key solutions, which encompass design, construction, commissioning, and operational support. By serving diverse sectors such as paper, food and beverage, and chemicals, Aqwise helps clients address critical issues related to water scarcity, environmental pollution, and regulatory compliance, all while minimizing investment and operational costs.
Safend specializes in Data Leakage Prevention (DLP) solutions for enterprise endpoints. The company's flagship product, the Safend Data Protection Suite, offers a unified approach to safeguarding against data loss, misuse, and theft through a single server, management console, and agent architecture. This suite includes modules for encrypting internal hard drives, controlling ports and devices, inspecting and blocking sensitive content, mapping and locating sensitive data, generating compliance reports, and auditing endpoints. Safend's solutions are used by security-conscious enterprises, governmental agencies, and small to medium-sized businesses (SMBs) across various sectors including federal, state, and local government, healthcare, finance, and retail. The company helps these organizations comply with industry regulations such as HIPAA, PCI, SOX, and multiple privacy laws. Safend distributes its products internationally through a network of resellers and partners.
Medingo Medical Solutions
Venture Round in 2007
Medingo develops and produces miniature medical devices for people with diabetes. The company's flagship product is the Solo MicroPump, a tiny insulin pump that allows people with diabetes to deliver insulin discreetly without tubing or needles. The company was founded in 2005 and is based in Yoqneam Illit, Israel and the US Corporate Office is in Tampa, FL.
Enure Networks
Venture Round in 2007
Enure Networks is an Israeli-based company founded in 2003 that specializes in home-network management and self-healing software solutions. It offers a range of services for the installation and maintenance of home/SOHO (Small Office/Home Office) networked services, including VoIP, IPTV, business-critical applications, and converged triple and quadruple play applications. The company provides high-speed internet solutions, VoIP performance management, security risk assessments, and IPTV-specific challenges handling. Additionally, Enure Networks offers a True Information & Control server to manage data flow in home networks. With operations in the United States and Europe, the company aims to ensure seamless network experiences for users by automatically addressing any deviations from optimal network conditions.
MuseStorm
Series A in 2007
MuseStorm school is a fantastic opportunity to advance their professional career. The MUSEstorm IT School offers life-changing opportunities.
POCARED Diagnostics
Venture Round in 2007
POCARED Diagnostics Ltd. is a medical device company based in Rehovot, Israel, that specializes in innovative in-vitro diagnostic solutions. Founded in 2004, the company has developed a next-generation microbiology platform known as the P-1000, which enables real-time, reagentless analysis of human fluids and specimens. This fully automated system allows for the rapid detection, quantification, and identification of pathogenic bacteria and yeast, significantly reducing the time required for result reporting from several days to just minutes. By streamlining the diagnostic process, POCARED Diagnostics enhances the ability of physicians to quickly diagnose and treat infectious diseases, ultimately improving patient outcomes. The company operates as a subsidiary of Naftali Investments Ltd.
Founded in 2005, RADLIVE develops high definition telephony technologies, products and applications. RADLIVE's innovative solutions and unique technology will transform the way users and organizations all over the world communicate and collaborate with each other. RADLIVE is a member of the RAD Group, a collection of independent companies that develop, manufacture and market solutions for diverse segments of the networking and telecommunications industry. Closed February 2010.
Journeys
Seed Round in 2007
Journeys, based in Israel, is a both a virtual world and MMOG (Massively Multiplayer Online Game). Journeys is a participant at the 2008 IsraelWebTour.
BPT is developing and commercializing advanced membranes-based separation solutions addressing the unique needs of the water and wastewater treatment for key industrial processes. BPT patented chemically-stable membrane technology enable customers in the landfill, mining, chemical, biopharma and food industries to comply with the environmental regulations, reuse water and reduce production costs. BPT membranes are field proven to enable lowest cost reclamation of some of the most aggressive and vexing industrial waste water streams.
Enure Networks
Series A in 2006
Enure Networks is an Israeli-based company founded in 2003 that specializes in home-network management and self-healing software solutions. It offers a range of services for the installation and maintenance of home/SOHO (Small Office/Home Office) networked services, including VoIP, IPTV, business-critical applications, and converged triple and quadruple play applications. The company provides high-speed internet solutions, VoIP performance management, security risk assessments, and IPTV-specific challenges handling. Additionally, Enure Networks offers a True Information & Control server to manage data flow in home networks. With operations in the United States and Europe, the company aims to ensure seamless network experiences for users by automatically addressing any deviations from optimal network conditions.
Safend specializes in Data Leakage Prevention (DLP) solutions for enterprise endpoints. The company's flagship product, the Safend Data Protection Suite, offers a unified approach to safeguarding against data loss, misuse, and theft through a single server, management console, and agent architecture. This suite includes modules for encrypting internal hard drives, controlling ports and devices, inspecting and blocking sensitive content, mapping and locating sensitive data, generating compliance reports, and auditing endpoints. Safend's solutions are used by security-conscious enterprises, governmental agencies, and small to medium-sized businesses (SMBs) across various sectors including federal, state, and local government, healthcare, finance, and retail. The company helps these organizations comply with industry regulations such as HIPAA, PCI, SOX, and multiple privacy laws. Safend distributes its products internationally through a network of resellers and partners.
BrainsGate
Venture Round in 2005
BrainsGate, Ltd. is a medical device company based in Caesarea, Israel, specializing in therapies for central nervous system diseases, particularly acute ischemic stroke. Founded in 2000, the company has developed a technology platform that utilizes electrical stimulation of the spheno-palatine ganglion (SPG) to enhance cerebral blood flow. Its innovative treatment approach involves a miniature electrode implanted in the roof of the mouth through a minimally invasive procedure performed under local anesthesia. BrainsGate's key product is an ischemic stroke system that delivers targeted stimulation to the SPG, with the aim of improving outcomes for stroke patients. The company has conducted significant clinical trials, including a pivotal study with 300 participants that demonstrated the safety and efficacy of its treatment. Currently, BrainsGate is advancing the ImpACT-24b trial, a multinational randomized study assessing the treatment's effectiveness within a critical 24-hour window following stroke onset.
Teledata Networks
Venture Round in 2005
Teledata Networks is a leading global provider of innovative Access Network solutions and products for telecom service providers. The company creates solutions that enable a smooth migration path to Next Generation Networks (NGN) and support a full Triple Play service portfolio.
ChipX
Venture Round in 2004
ChipX, Inc. is a Mixed-Signal ASIC company with the broadest offering of value-added ASIC solutions, including Standard Cell, Structured ASIC and Hybrid ASIC technology. ChipX has unique expertise in PCI Express, USB 2.0, DDR/DDR2 and data conversion mixed-signal cores; all are silicon proven and certified and they can be integrated in customers’ ASICs with a record first-time to market success. ChipX products are widely used in industrial applications, medical equipment and military/aerospace systems. Headquartered in Santa Clara, CA, ChipX is a privately held corporation, with a Research and Development subsidiary in Israel.
ForeseeHome
Series A in 2003
Notal Vision is developing the first comprehensive diagnostic solution for the early detection and frequent monitoring of Age-Related Macular Degeneration (AMD), the leading cause of blindness in the western world today. Early detection of ARM can allow doctors to treat patients at an earlier stage and possibly prevent any loss of sight. A true pioneer in the eye care industry, Notal Vision has developed and introduced the first home-based monitoring system for AMD patients, the ForeseeHome™ AMD Monitoring Program.
Chip Express
Venture Round in 2002
Fit the CHIP Express™ digital diesel tuning box for more torque too. You'll immediately notice better acceleration from low down in the rev range and when using taller gears. And that means more pulling power - precisely what you need if you tow a caravan, a horse box, a boat or if you drive a heavily laden vehicle like a van or pickup.
Mediagate
Venture Round in 2000
mediagate develops and sells iPost Universal Messaging, a carrier-class universal messaging solution. iPost Universal Messaging is comprised of iPost application software and carrier-grade, third-party hardware. iPost Universal Messaging enables subscribers to manage multi-media messages, voice, fax, email and page, from within a single mailbox using any email client (Outlook, Hotmail, Netscape Mail, Eudora, etc.), from anywhere in the world, any time of the day or week. Subscribers can use any telephone, mobile phone, PDA, computer, laptop, fax machine, and WAP and SMS-enabled device to manage their messages.